Literature DB >> 34643878

Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism.

J Wei1, Z Liu2, J He1, Q Liu3, Y Lu1, S He1, B Yuan1, J Zhang4, Y Ding5.   

Abstract

Chemotherapy is one of the most commonly used clinical treatments among the currently available cancer therapies. However, the phenomenon of Multidrug resistance (MDR) has become a challenge in the treatment process, weakening the impact of chemotherapy. Extensive research on elucidating the development of cancer MDR has identified the following mechanisms that play a critical role in the development of several MDR reversal agents: abnormal expression of cell membrane transporters, adaptation of cancer cells to the microenvironment, regulation of hypoxia, repair of DNA damage and reduction of apoptosis, the enhancement of the EMT process, the existence of cancer stem cells (CSCs), and the abnormal activation of key signaling pathways. However, they failed to demonstrate significant efficacy due to severe side effects during their clinical trials. Traditional Chinese medicines (TCMs) are known to play an important anti-cancer role since they have low toxicity, high efficacy, and safety and can reverse MDR. TCMs reversal agents can be divided into Chinese medicine monomers, synthetic monomers, analogs, or derivatives. Several studies have shown that TCMs can effectively overcome cancer MDR and can be effectively used for treating cancer patients.
© 2021. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Cancer; Mechanism; Multidrug resistance; Traditional Chinese medicines

Mesh:

Year:  2021        PMID: 34643878     DOI: 10.1007/s12094-021-02716-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  101 in total

Review 1.  Insights into new mechanisms and models of cancer stem cell multidrug resistance.

Authors:  Y Garcia-Mayea; C Mir; F Masson; R Paciucci; M E LLeonart
Journal:  Semin Cancer Biol       Date:  2019-07-29       Impact factor: 15.707

2.  Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin.

Authors:  Zeting Yuan; Xiaojing Shi; Yanyan Qiu; Tingting Jia; Xia Yuan; Yu Zou; Cheng Liu; Hui Yu; Yuxia Yuan; Xue He; Ke Xu; Peihao Yin
Journal:  Oncol Rep       Date:  2017-01-30       Impact factor: 3.906

3.  MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.

Authors:  Xiao Lu; Rui Liu; Meina Wang; Alagamuthu Karthick Kumar; Feiyan Pan; Lingfeng He; Zhigang Hu; Zhigang Guo
Journal:  Oncogene       Date:  2019-08-30       Impact factor: 9.867

4.  Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.

Authors:  Luhua Meng; Xuejun Xia; Yanfang Yang; Jun Ye; Wujun Dong; Panpan Ma; Yiqun Jin; Yuling Liu
Journal:  Int J Pharm       Date:  2016-09-03       Impact factor: 5.875

5.  Let-7e Suppresses DNA Damage Repair and Sensitizes Ovarian Cancer to Cisplatin through Targeting PARP1.

Authors:  Man Xiao; Jianfeng Guo; Lisha Xie; Chun Yang; Lanqing Gong; Zehua Wang; Jing Cai
Journal:  Mol Cancer Res       Date:  2019-11-13       Impact factor: 5.852

Review 6.  Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells.

Authors:  Z Ouar; R Lacave; M Bens; A Vandewalle
Journal:  Cell Biol Toxicol       Date:  1999-04       Impact factor: 6.691

7.  GATA3 as a regulator for naughty cancer-associated fibroblasts in the microenvironment of high-grade serous ovarian cancer.

Authors:  Amr Ahmed El-Arabey; Mohnad Abdalla
Journal:  Hum Cell       Date:  2021-08-25       Impact factor: 4.174

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.

Authors:  Youngjin Han; Boyun Kim; Untack Cho; In Sil Park; Se Ik Kim; Danny N Dhanasekaran; Benjamin K Tsang; Yong Sang Song
Journal:  Oncogene       Date:  2019-08-13       Impact factor: 9.867

10.  Extreme low dose of 5-fluorouracil reverses MDR in cancer by sensitizing cancer associated fibroblasts and down-regulating P-gp.

Authors:  Yan Ma; Yuhua Wang; Zhenghong Xu; Yongjun Wang; John K Fallon; Feng Liu
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

View more
  3 in total

1.  Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation.

Authors:  Junjun Ling; Yuhong Wang; Lihai Ma; Aoshuang Chang; Lingzhan Meng; Liang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-13       Impact factor: 2.650

2.  Kanglaite (Coix Seed Extract) as Adjunctive Therapy in Cancer: Evidence Mapping Overview Based on Systematic Reviews With Meta-Analyses.

Authors:  Cuncun Lu; Shuilin Wu; Lixin Ke; Fumei Liu; Wenru Shang; Xiuxiu Deng; Yanli Huang; Qiang Zhang; Xin Cui; Alexios-Fotios A Mentis; Yanming Xie; Zhifei Wang
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

3.  Network Pharmacology-Based Analysis of the Potential Biological Mechanisms of Coix Seed against Colorectal Cancer.

Authors:  Yi Sun; Peishi Jiang; Hongjie Yang; Zhichun Zhang; Yuanda Zhou; Peng Li; Qingsheng Zeng; Xipeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-06       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.